ClinicalTrials.gg

Program

Fluoride Toothpaste

Also written as “1.1% Fluoride toothpaste” and “0.243% Fluoride toothpaste”.

Its studies are mostly in Dental Caries, led by Colgate Palmolive.

Furthest: phase 3, since Dec 10, 20242 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Colgate Palmolive20 open or runningphase 3since Dec 10, 2024Mar 4, 2016none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 4, 2016First study: phase 2 study in Dental CariesFirst studyNCT02708160
  2. Dec 10, 2024Phase 3 study in Tooth DemineralizationNCT06732518 · 36 enrolled · Brazil

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06732518Tooth Demineralization · Brazil3CompletedApr 24, 202536
NCT02708160Dental Caries2WithdrawnJun 20160

How it is read

Names in the registry

  • “Fluoride Toothpaste”, 1 entry
  • “1.1% Fluoride toothpaste”, 1 entry
  • “0.243% Fluoride toothpaste”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.